AVEO Pharmaceuticals, Inc. — PY2024
Reporting company × program yearGeneral Payments
AVEO Pharmaceuticals, Inc. reported the General Payments below to CMS for program year 2024. The figures are that company's reported total for that year alone; they are not a total across years and are never combined with any other company's.
Reported total — AVEO Pharmaceuticals, Inc. — PY2024
$432,140.68
- Category: General Payments
- Program year: 2024
- Records: 4,789
- Providers: 3,285
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
Totals sum the General Payments records CMS published with this reporting entity and this program year. A record is counted once, under the year CMS assigned it.
How this figure is calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- Methodology & Data — sourcing, labeling, and limitations.
This intersection
This page exists because CMS's published records contain this intersection. Pairs with no published records have no page — nothing here is computed for a combination CMS did not report. Figures are General Payments only, reported to physicians and non-physician practitioners. Payments to teaching hospitals are not included, and the separate Research and Ownership datasets are never combined with these figures.